Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function
Current Oncology · 06.12.2023 · 30 (12) · 10336-10350
DOI: 10.3390/curroncol30120753 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 06.12.2023. Verfasst von Daniel Strüder und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery "Otto Körner", Rostock University Medical Center, D-18057 Rostock, Germany. Hauptthemen laut MEDLINE: Deglutition Disorders, Head and Neck Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC) is linked to significant morbidity, adversely affecting survival and functional capacity. Post-treatment challenges such as pain, dysphonia, and dysphagia are common, prompting increased attention in survivorship research. Quality of Life (QoL) questionnaires, especially the MD Anderson Dysphagia Inventory (MDADI), are prevalent outcome measures in clinical studies but often lack parallel objective swallowing function evaluations, leading to potential outcome discrepancies. This study aimed to illuminate the relationship between subjective QoL (EQ-5D-5L and MDADI) measures and objective swallowing function (evaluated via Fiberoptic Endoscopic Evaluation of Swallowing, FEES) in patients with HNSCC. The analysis revealed a notable discordance between objective measures of swallowing function, such as the Penetration–Aspiration Scale (PAS) and residue ratings in the vallecula or piriform sinus, and patients’ subjective QoL assessments (p = 0.21). Despite the lack of correlation, swallowing-related QoL, as measured by the MDADI, was more indicative of disease severity than generic QoL assessments. Generic QoL scores did not demonstrate substantial variation between patients. In contrast, MDADI scores significantly declined with advancing tumor stage, multimodal therapy, and reliance on feeding tubes. However, the clinical significance of this finding was tempered by the less than 10-point difference in MDADI scores. The findings of this study underline the limitations of QoL measures as standalone assessments in patients with HNSCC, given their reliance on patient-perceived impairment. While subjective QoL is a crucial aspect of evaluating therapeutic success and patient-centric outcomes, it may fail to capture critical clinical details such as silent aspirations. Consequently, QoL assessments should be augmented by objective evaluations of swallowing function in clinical research and practice to ensure a holistic understanding of patient well-being and treatment impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Head and Neck Surgery "Otto Körner", Rostock University Medical Center, D-18057 Rostock, Germany.
- Department of Otorhinolaryngology, Head and Neck Surgery, RWTH Aachen University Hospital, D-52074 Aachen, Germany.
ORCID-Profile: Daniel Strüder, Robert Mlynski
Zitieren
APA
Strüder, D., Ebert, J., Kalle, F., Schraven, S. P., Eichhorst, L., Mlynski, R., & Großmann, W. (2023). Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function. Current Oncology, 30(12), 10336-10350. https://doi.org/10.3390/curroncol30120753
Vancouver
Strüder D, Ebert J, Kalle F, Schraven SP, Eichhorst L, Mlynski R, et al. Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function. Current Oncology. 2023;30(12):10336-10350. doi:10.3390/curroncol30120753
BibTeX
@article{Strder2023,
author = {Strüder, Daniel and Ebert, Johanna and Kalle, Friederike and Schraven, Sebastian P and Eichhorst, Lennart and Mlynski, Robert and Großmann, Wilma},
title = {Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {12},
pages = {10336--10350},
doi = {10.3390/curroncol30120753}
}
EUVIMED